|
|
||||||||
J Thorac Cardiovasc Surg 2007;134:579-586
© 2007 The American Association for Thoracic Surgery
Cardiopulmonary Support and Physiology |
a Cardiac Technology Centre, Kolling Institute,
b Department of Cardiology at Royal North Shore Hospital, University of Sydney, Australia
Received for publication December 20, 2006; revisions received February 23, 2007; accepted for publication March 26, 2007. * Reprint requests: James Mau, BSc, MB, BS, Cardiac Technology Centre, Block 4, Level 3, Royal North Shore Hospital, Pacific Hwy, St Leonards, Sydney, NSW, Australia 2065 (Email: jmau{at}med.usyd.edu.au).
| Abstract |
|---|
|
|
|---|
Methods: Twelve sheep underwent percutaneous transluminal septal myocardial ablation using 0.6 mL ethanol. Twelve other sheep underwent a sham procedure. Left ventricular and right ventricular pressure and volume (conductance) response 15 minutes and 4 weeks postinjury were measured. Ultrasonic crystals measured chamber dimensions and wall movement. Areas at risk and infarct zones were quantified.
Results: Compared with sham, ablation chronically reduced systolic interventricular septal thickening (18.4% ± 5.8% vs 7.3% ± 3.1%; P < .001) and acutely increased right ventricular ejection fraction (37.6% ± 8.5% vs 69.9% ± 7.2%; P < .001), preload recruitable stroke work (42.0 ± 4.4 erg · 103 vs 48.7 ± 2.0 erg · 103, P < .001), end-systolic elastance (1.03 ± 0.19 mm Hg mL–1 vs 1.31 ± 0.18 mm Hg mL–1; P < .001), and Tau (24.9 ± 3.8 ms vs 29.6 ± 8.2 ms; P < .001). In contrast, for left ventricular ejection fraction (55.5% ± 5.9% vs 38.9% ± 7.7%; P < .001), preload recruitable stroke work (85.9 ± 10.6 mm Hg vs 66.5 ± 9.6 mm Hg; P < .001) and elastance (2.13 ± 0.51 mm Hg mL–1 vs 1.81 ± 0.44 mm Hg mL–1; P < .001) were reduced, but Tau increased (22.0 ± 3.5 ms vs 28.9 ± 5.8 ms; P < .001) and remained elevated at 4 weeks compared with sham. The area at risk was the same between groups, and injury was limited to the septum (17.2% ± 2.7% vs 2.9% ± 5.8%; P < .001).
Conclusions: Acute and chronic hemodynamic responses are distinctly different after septal injury; the acute response demonstrates a paradoxical motion. Resolution of this motion at 4 weeks is suggestive of reduced septal compliance and buttressing. Ventricular interactions after placement of a left ventricular assist device will vary depending on the injury duration.
| Introduction |
|---|
|
|
|---|
|
Interest in right ventricular (RV) failure after acute mechanical left ventricular (LV) unloading for end-stage heart failure has followed the landmark REMATCH study1
and the recent report by Birks and colleagues,2
with implications for LV assist devices as destination therapy. Perioperative RV failure affects up to 25% of recipients and results in inadequate device filling and compromised multiple organ function.3
To avoid prolonged use of inotropes that can further impair RV function, severely ill recipients often require implantation of an additional right-sided support device.4
Disruption of septal position and function because of device-induced chamber attenuation has been demonstrated to contribute to altered RV contractility,5
load,6
and compliance7
by interfering with ventricular interdependence. Although it has been proposed that worsened RV decompensation results from coexisting septal damage, investigations have been confined to reversible septal injury.8
Percutaneous transluminal septal myocardial ablation with ethanol,9
developed as a treatment for hypertrophic obstructive cardiomyopathy,10
has enabled detailed study of ventricular interaction after both acute and chronic septal damage.
This study describes the acute and chronic biventricular response to ethanol ablation in a sheep model, using both steady-state load-independent and in-series measures. The findings aim to provide guidance on the likely need for RV support when LV mechanical assist device implantation is contemplated.
| Materials and Methods |
|---|
|
|
|---|
Septal Myocardial Ablation
The right jugular vein was cannulated, and a Capsure SP-4524 59-cm bipolar pacemaker lead (Medtronic; Minneapolis, Minn) was secured to the RV endocardial apex fluoroscopically and connected to a Sigma SR 300 implantable single-chamber bipolar pacemaker (Medtronic) programmed to a hysteresis of 50 beats/min and pacing rate of 80 paces/min. A 2.0 x 9-mm Maverick SoftLEAP over-the-wire balloon catheter (Boston Scientific, Natick, Mass) was mounted on a standard 0.3556-mm angio wire, guided into the main septal perforating artery and positioned fluoroscopically with proximal clearance of the left anterior descending coronary artery. Correct positioning of the radio-opaque markers within the main septal perforator was considered completion of a sham procedure. A repeat angiogram verified patency. Active ablation involved balloon inflation to 8 atmospheres pressure followed by an immediate bolus injection of 0.6 mL of ethanol (99.6%). Repeat angiography at 10 minutes in this group verified postablative main septal perforator closure and left anterior descending patency (Figure 1).
|
Open chest ventricular dimension measurements involved placement of 2 pairs of 2-mm ultrasonic transducers (Sonometrics Corporation; London, Ontario) on the RV and LV free wall epicardium and endocardium and another pair on the RV and LV surface of the septum at the midpapillary level. A left thoracotomy with removal of the fifth rib provided access to the heart and great vessels, and the pericardium was incised along its left anterior edge from apex to base. All transducers were placed in an equatorial plane across the cardiac short axis, and their position was verified at postmortem. Ultrasonic flow probes (16 and 20 mm) (Transonic Systems Inc, Ithaca, NY) were positioned around the aorta and pulmonary artery, respectively, and the incised pericardium was repositioned and resutured around the instrumented heart.
Hemodynamic Assessment
Data were collected at baseline and 15 minutes and 4 weeks after injury. Measurements were taken after at least 30 minutes of stable anesthesia at end expiration and included the following: biventricular measurements of (1) preload recruitable stroke work (PRSW), (2) end-systolic pressure volume relationship (Ees), (3) ejection fraction (EF), (4) Tau (early diastolic relaxation, calculated as the time from dP/dtmin until pressure reached
dP/dtmin), (5) central venous pressure (CVP), (6) RV peak systolic and end-diastolic pressure, and (7) pulmonary wedge pressure as previously described.11
Conductance measurements were calibrated against stroke volume values obtained from the respective flow probes.
Infarct Size Determination
At the completion of chronic hemodynamic measurements, hearts were excised and washed in normal saline before the left and right main coronary arteries and the main septal perforating artery were cannulated; 1% triphenyltetrazolium was used to selectively perfuse the main septal perforator at 100 mm Hg to determine infarct size,12
with simultaneous perfusion of 10% methylene blue into the left and right coronary systems at equivalent pressures. Weights of the ventricles, areas at risk, and ablated zones were quantified by volume displacement and digital photo planimetry. Location of septal ultrasonic crystals in the central region of septal ablation was verified.
Data Analysis
Steady-state hemodynamic parameters were calculated as the average of 8 beats (including LV and RV end-systolic and end-diastolic pressures and volumes). PRSW relationship was calculated from the plot of stroke work against its loading end-diastolic volume, and slope of the Ees was derived as previously described.11
End-diastolic and end-systolic crystal-derived dimensions were also analyzed as the average of 8 cardiac cycles during steady-state conditions. End diastole was defined as the time of peak electrocardiogram R wave, and RV and LV end systole were defined as the point of zero pulmonary or aortic flows, respectively. Fractional systolic change in wall thickness was calculated from sonomicrometry-derived dimensions as (end-systolic–end-diastolic dimension)*100/end-diastolic dimension. Randomly coded digital photographs of infarct zones were analyzed by a blinded operator using Sigma Scan Image v2.03 (SPSS Inc, Chicago, Ill). Pacemaker interrogation provided a 4-week history of pacing need.
Statistical Analysis
The results are presented as means ± standard deviation. For all parameters, comparisons between sham and ablation groups were calculated using a 2-tailed t test for parametric distributions or, where data failed a normality test, a Mann–Whitney rank–sum test for nonparametric distributions. All statistical analyses were performed using SigmaStat Statistical Software v2.03 (SPSS Inc).
| Results |
|---|
|
|
|---|
Load-independent and In-series Hemodynamic Data
Despite ethanol ablation, CVP, LV peak systolic pressure, LV and RV stroke volume, and cardiac output were not significantly different between sham and ablation groups. LV stroke volume averaged 57.1 ± 6.6 mL, 54.9 ± 11.0 mL, and 56.3 ± 8.0 mL for the sham group and 53.3 ± 10.3 mL, 47.2 ± 12.1 mL, and 52.0 ± 12.5 mL for the ablation group at baseline, 15 minutes, and 4 weeks (P values = .229, .068, .290), respectively. RV stroke volume averaged 57.4 ± 6.3 mL, 54.5 ± 10.1 mL, and 56.6 ± 7.8 mL for the sham group and 53.5 ± 9.0 mL, 48.3 ± 13.0 mL, and 54.1 ± 13.7 mL for the ablation group at baseline, 15 minutes, and 4 weeks (P values = .173, .148, .559), respectively. LV cardiac output averaged 4.1 ± 0.5 L/min, 3.9 ± 0.8 L/min, and 4.0 ± 0.6 L/min for the sham group and 3.7 ± 0.4 L/min, 3.6 ± 0.4 L/min, and 3.6 ± 0.4 L/min for the ablation group at baseline, 15 minutes, and 4 weeks (P values = .074, .637, .105), respectively. RV cardiac output averaged 4.1 ± 0.5 L/min, 3.9 ± 0.7 L/min, and 4.0 ± 0.6 L/min for the sham group and 3.7 ± 0.5 L/min, 3.7 ± 0.5 L/min, and 3.8 ± 0.6 L/min for the ablation group at baseline, 15 minutes, and 4 weeks (P values = .800, .494, .193) respectively.
Although pulmonary wedge pressure and RV peak systolic pressures in the ablation and sham groups were not statistically different at 4 weeks (P = .129, .904, respectively), they were higher in the ablation group at 15 minutes after intervention compared with sham values (P < .001 and P = .044, respectively, Figure 2). EFs and pressure volume derivatives are illustrated in Figure 3. RV PRSW, Ees, and EF values were higher 15 minutes after intervention compared with sham values, whereas LV values were lower (P < .001). There was no difference in PRSW, Ees, and EF values between groups at 4 weeks (RV: P = .516, .669, and .086; LV: P = .730, .581, and .349, respectively). RV and LV Tau values were higher 15 minutes after intervention compared with sham and remained higher at 4 weeks. As shown in Figure 4, LV end-systolic and end-diastolic volumes were higher, and corresponding RV volumes were lower at 15 minutes in ablation animals compared with sham animals (P < .001). Comparison of RV and LV summed end-diastolic and end-systolic volumes revealed that overall cardiac volume was maintained at 15 minutes and 4 weeks, with P values of .664 and .060 for 15 minutes and .233 and .244 for 4-week comparisons, respectively (Figure 4).
|
|
|
|
| Discussion |
|---|
|
|
|---|
Systolic Heart Function
Acutely, CVP and RV end-diastolic pressures were unaffected by ablation (Figure 2), whereas RV peak systolic pressure, Ees, PRSW, and EF were higher compared with sham values (Figure 3). This indicates no detriment to overall RV function. In contrast, in-series LV functional (pulmonary wedge pressures and EF) and load-independent indices were acutely impaired. Thus, in contrast with classic theory,13
a clear increase in wedge pressure after acute injury was identified. We postulate that this is caused by unmasking of an intact RV pressure/volume response during LV contractile failure, with maintenance of LV forward flow aided by elevated LV filling pressure. All systolic parameters returned to baseline by 4 weeks, indicating LV functional recovery (Figure 3). This is the first study to identify distinct differences between acute and chronic hemodynamic response after isolated septal injury. It also challenges and extends previous theories that sought to explain the phenomenon of RV failure after LV mechanical assistance using studies confined to acute, reversible ischemic models.8
Here we demonstrate that the chronic response to septal injury is distinctly different.
Diastolic Heart Function
Disruption of diastolic function resulting from myocardial injury is conditional on the specific pathology present and the resulting cellular response, including the action of matrix metalloproteinases and their tissue inhibitors.14
Reduction in tissue inhibitor of metalloproteinase-4 appears to be characteristic of ethanol ablation.15
We have demonstrated that ethanol ablation acutely prolongs left and RV relaxation times (Tau), which remain abnormal at 4 weeks (Figure 3). This is supported by other studies that revealed delayed RV early diastolic relaxation in response to acute septal16
and LV17
and RV18
free wall ischemia, as well as in the chronic setting after LV19
and RV20
infarction. This persistence of impaired diastolic relaxation after 4 weeks indicates a change that mirrors the reduction in tissue inhibitor of metalloproteinase-4.
Ventricular Interdependence and Geometry
The role of the septum in maintaining LV and RV interdependence mechanisms is paramount.21,22
Physiologic pressure gradients are governed by active septal myocardial sarcomeric mechanisms with the end-diastolic relational position of the septum between the ventricles constituting a form of "septal preload."23
Removal of active septal systole under conditions of unaltered myocardial compliance, such as that induced by ischemia or paralysis, results in paradoxical motion of the septum into the RV at points in the cardiac cycle where LV pressure dominates. Associated sarcomeric lengthening continues until its maximal length is reached and passive restraint prevents further RV-vectored motion.22
Thus, according to the law of conservation of mass that describes associated increases in surface area of tissue under compression, transeptal pressure induces sarcomeric stretching and septal surface area expansion. Eventually, at maximal or close to maximal sarcomeric length, septal position becomes entirely subject to fluctuating pressure gradients and oscillates paradoxically throughout the cardiac cycle.
Because of the asymmetric RV shape and its tendency to alter with loading, we used the conductance method to avoid geometric assumptions. Compared with the tricuspid axis, the pulmonary axis provides better RV volumetric data and avoids the risk of right atrial sampling during diastolic tricuspid valve descent. In this study, a transvenous tricuspid approach was used to avoid an open chest procedure; however, conductance-derived stroke volume values were calibrated with a pulmonary flow probe. The conductance pattern after ablation reveals maintenance of stroke volume in both ventricles with an immediate reduction in LV EF and mirrored increases in RV EF (Figure 3). By 4 weeks, all acutely altered geometry returns to baseline values. LV and RV end-systolic and end-diastolic volume analysis reveals unaltered summed LV and RV (biventricular) volume and equal degrees of LV dilatation and RV shrinkage (Figure 4). Thus, the exaggerated septal motion in systole leads to an increase in RV EF and a decrease in RV end-systolic volume. In turn, this sets up subsequent diastole, with decreased RV volume improving filling potential of the LV. The net effect is a minimal change to cardiac output and overall heart volume, suggesting either that physiologic septal movement in unison with the LV free wall is a redundant action or that additional factors are in operation to compensate for the offset hemodynamic performance induced by septal injury. Resolution of this motion after 4 weeks is suggestive of reduced septal compliance and buttressing.
Validation of Septal Dysfunction
Four weeks after ablation, our study showed a pattern of wall movement and dimensions similar to previous studies of acute septal8
and LV free wall ischemic injury.24
However, in contrast with sonomicrometric studies after anteroseptal infarction and temporary septal ischemia,25
we did not observe paradoxical septal thinning. Thus, either there is residual sarcomeric function to counteract passive thinning or there is chronic compliance change that passively resists altered transeptal pressure gradients. It is proposed that the latter mimics an ischemic fibrotic pattern.22
In addition to functional disruption, a conduction block requiring a 10-fold increase in temporary pacing was noted that resolved by 4 weeks (Table 1). Anatomic studies of the sheep conductive pathway have revealed a more robust and narrow cable-like bifascicular Purkinje system26
compared with the broader, more susceptible trifascicular pattern in humans.27
Thus, ready resolution of short-term atrioventricular nodal edema and swelling could explain our results. Prior human studies suggest that the need for interim pacing after septal ablation typically translates to chronic conductive pathway pathology.28
Postmortem Findings
Postmortem findings confirmed adequacy of ethanol volume used in our ablation animals, showing a 10-fold increase in the fibrotic area as a proportion of area at risk. Figure 1 illustrates that fibrosis was confined to a centralized mass of tissue inferior to the trigonum fibrosum, corresponding to the principal supply area of the main septal perforating artery. This pattern of septal damage is borne out by the sonomicrometric data demonstrating a decrease in septal thickening, consistent with ethanol ablation causing damage of a chronic nature and previous echocardiographic findings of postablative septal thinning at the midpapillary plane.29
| Conclusions |
|---|
|
|
|---|
Limitations
RV and LV function were investigated in an experimental model in which study of intrinsic septal function was confined to the chronic phase after ablation to avoid successive open chest procedures. A logical extension of this study would involve the assessment of septal function before and directly after ethanol ablation.
Implications
Ventricular interactions and acute RV failure etiology that often follow LV assist device implantation for severe heart failure have been characterized. Manifestation of occult RV dysfunction, LV geometric alterations resulting from LV unloading-induced LV volume minimization, and simple in-series interactions have all been implicated. The presence of septal ischemia has been shown to accentuate these processes.8
We have identified clear differences in ventricular interactions and geometry between acute and chronic septal injury under closed chest conditions. This extends the known pathophysiologic course after ethanol ablation and indicates that passive and active components of ventricular compliance and contractility are not interchangeable between ischemic and fibrotic pathologies. Thus, this study affords an avenue to further examine LV assist device interaction within a chronic pathologic setting. It calls into question the extrapolation of such interaction during acute septal injury as an explanation for abnormalities found in patients with a chronic component of septal disease.
| Acknowledgments |
|---|
| Footnotes |
|---|
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
J. Mau, S. Menzie, Y. Huang, M. Ward, and S. Hunyor Nonsurround, nonuniform, biventricular-capable direct cardiac compression provides Frank-Starling recruitment independent of left ventricular septal damage J. Thorac. Cardiovasc. Surg., July 1, 2011; 142(1): 209 - 215. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mau, S. Menzie, Y. Huang, M. Ward, and S. Hunyor Chronic septal infarction confers right ventricular protection during mechanical left ventricular unloading J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 172 - 178. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |